IntroCompany BackgroundSales Growth Over Last Ten YearsCompany NameAjanta Pharma Ltd.(Rs. Million)Firm AIncorporation year1979Year edningSalesGrowthIndustry groupDrugs & pharmaceuticalsMarch-031024.4Main product/service groupDrug formulationsMarch-041,206.517.8%NSE symbolAJANTPHARMMarch-051,788.048.2%First trading date on NSE5-Jun-2000March-062,123.718.8%BSE groupBMarch-072,471.716.4%First trading date on BSE5-Jun-2000March-082,916.918.0%March-093,224.310.5%March-103,850.019.4%March-114,624.120.1%March-126,123.732.4%March-138,452.438.0%March-1411,099.231.3%

Sheet2(Rs. Million)ActualSourceFYSalesGrowthBorrowingsNet WorthPATRet ProfitTotal AssetsPUCIGRSGRSales GrowthDERPayout RatioMarch-031024.4625.51721.742.642.62504.6118.00.360.0%ProwessMarch-041206.517.8%595.41725.33.63.62595.3118.00.14%0.21%17.8%0.350.0%ProwessMarch-051788.048.2%800.71013.174.474.42043.5118.03.78%7.93%48.2%0.790.0%ProwessMarch-062123.718.8%827.61096.5103.583.42222.4118.03.90%8.23%18.8%0.7519.4%ProwessMarch-072471.716.4%1084.91206.2137.1109.72721.8118.04.20%10.00%16.4%0.9020.0%ProwessMarch-082916.918.0%1650.61342.0177.9143.63542.2118.04.23%11.98%18.0%1.2319.3%ProwessMarch-093224.310.5%2402.21521.5213.8179.54582.9118.04.08%13.38%10.5%1.5816.0%ProwessMarch-103850.019.4%2032.91759.1285.4237.64658.0118.05.38%15.62%19.4%1.1616.7%ProwessMarch-114624.120.1%1582.92155.5464.5396.44808.6118.08.98%22.53%20.1%0.7314.7%ProwessMarch-126123.732.4%1903.22718.4664.9562.96188.6118.010.01%26.11%32.4%0.7015.3%ProwessMarch-138452.438.0%1234.63562.81011.2839.56760.5118.014.18%30.83%38.0%0.3517.0%ProwessMarch-1411,099.231.3%566.15363.22208.61797.08798.7176.725.67%50.39%31.3%0.1118.6%Company AR-30.13.690.70.0Div411.6171.7IGR = (PM * S * b) / (A PM * S * b)205.3-712.274.4-551.8PAT2208.61011.226.983.483.4178.91797.0839.5SGR = b * ROE / (1 b * ROE)257.3109.7109.7499.4565.7135.8143.6820.4751.6179.5179.51040.7-369.3237.6237.675.1-450.0396.4396.4150.6320.3562.9562.91380.0-668.6844.4839.5571.9-668.51800.41797.02038.2

Sheet1Tot CapitalReserves and fundsDef Tax LaibCurrent liabilities & provisionsBorrowingsTotal assetsDER3/31/031181603.739.6117.8625.52504.60.363/31/041181607.368.1206.5595.42595.30.353/31/05118895.1229.7800.72043.50.793/31/06118978.5298.3827.62222.40.75512.87223/31/071181088.2430.71084.92721.80.9025253/31/08118122475.5474.11650.63542.21.2328.329.83/31/091181403.5131.25282402.24582.91.583/31/101181641.1123.2742.82032.946581.16566.1776.83/31/111182037.5188.6881.61582.94808.60.733/31/121182600.4187.91379.11903.26188.60.703/31/131183444.8243.21719.91234.66760.50.353/31/14176.75186.5229.82639.6566.18798.70.111714.41813Chng in AssetSource of Funding03.628.588.7-30.190.790.70-712.2-68.123.2205.3-551.8-551.8083.4068.626.9178.9178.90109.70132.4257.3499.4499.40135.875.543.4565.7820.4820.40179.555.753.9751.61040.71040.70237.6-8214.8-369.375.175.10396.465.4138.8-450150.6150.60562.9-0.7497.5320.3138013800844.455.3340.8-668.6571.9571.958.71741.7-13.4919.7-668.52038.22038.2